Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: €0 M
• Last 3 months FTD volume: €19.47 M
• Last 12 months FTD volume: €42.86 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
MannKind Corp MNKD	€0.51 M	€1.31 M	🇺🇸 USA
Eli Lilly LLY	€0.29 B	€0.42 B	🇺🇸 USA
Baxter BAX	€26.96 M	€86.01 M	🇺🇸 USA
Pfizer PFE	€29.26 M	€0.10 B	🇺🇸 USA
Sanofi SNY	€9.04 M	€67.5 M	🇫🇷 France
Johnson & Johnson JNJ	€57.52 M	€0.10 B	🇺🇸 USA